The Effect of Oral Corticosteroid on the Treatment of Trigger Finger in the Diabetic Patients.

The Effectiveness of Oral Corticosteroid in Improving of Trigger Finger in the Diabetic Patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016060528266N1

Enrollment

106

Registered

2016-07-10

Start date

2015-11-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes and Trigger finger. Trigger finger, Nodular tendinous disease, Diabetes

Interventions

Giving 5 mg of Prednisolone three times a day for two weeks in all patients without control group.

Treatment - Drugs

Giving 5 mg of Prednisolone three times a day for two weeks in all patients without control group

Eligibility

Sex/Gender

Female

Age

30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Having 30-60 years of age and being female diabetic patient with trigger finger. Exclusion Criteria: Not being/having Inflammatory arthritis; Uncontrolled high blood pressure; HbA1c more than 8; Previous treatment for trigger finger; Gastrointestinal problems; Non steroidal Anti-Inflammatory Drugs (NSAIDS) users and other kinds of Peri Arthritis in the hand.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Decrease in Quinnell grade. Timepoint: Before and 3 ,6 week and 3 months after the treatment. Method of measurement: Quinnell grading.	—

Secondary

Measure	Time frame
Increase in HbA1c level. Timepoint: Before and 3 months after the treatment. Method of measurement: Blood test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Niksolat

Mazandaran University of Medical Sciences

F.niksolat@yahoo; comhadimajidi2000@yahoo.com+98 11 3335 0672

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026